Implantable anti-angiogenic scaffolds for treatment of neovascular ocular pathologies.
Drug Deliv Transl Res
; 10(5): 1191-1202, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-32232681
ABSTRACT
The retinal physiology can accrue oxidative damage and inflammatory insults due to age and metabolic irregularities. Two notable diseases that involve retinal and choroidal neovascularization are proliferative diabetic retinopathy and wet age-related macular degeneration. Currently, these diseases are mainly treated with anti-VEGF drugs (VEGF = vascular endothelial growth factor), generally on a monthly dosage scheme. We discuss recent developments for the treatment of these diseases, including bioactive tissue-engineered materials, which may reduce frequency of dosage and propose a path forward for improving patient outcomes. Graphical abstract Development of materials for long-term intravitreal delivery for management of posterior segment diseases.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retinal Neovascularization
/
Choroidal Neovascularization
/
Diabetic Retinopathy
/
Wet Macular Degeneration
Limits:
Humans
Language:
En
Journal:
Drug Deliv Transl Res
Year:
2020
Document type:
Article
Affiliation country:
United States